1. Home
  2. HNVR vs IPHA Comparison

HNVR vs IPHA Comparison

Compare HNVR & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Bancorp Inc.

HNVR

Hanover Bancorp Inc.

N/A

Current Price

$27.13

Market Cap

193.0M

Sector

Finance

ML Signal

N/A

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

N/A

Current Price

$2.05

Market Cap

165.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HNVR
IPHA
Founded
2008
1999
Country
United States
France
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.0M
165.3M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
HNVR
IPHA
Price
$27.13
$2.05
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$24.50
$5.75
AVG Volume (30 Days)
27.5K
184.0K
Earning Date
04-27-2026
03-26-2026
Dividend Yield
1.72%
N/A
EPS Growth
N/A
N/A
EPS
0.80
N/A
Revenue
N/A
N/A
Revenue This Year
$35.49
$180.36
Revenue Next Year
$8.61
N/A
P/E Ratio
$34.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.91
$1.18
52 Week High
$27.89
$2.71

Technical Indicators

Market Signals
Indicator
HNVR
IPHA
Relative Strength Index (RSI) 55.33 46.64
Support Level $26.41 $1.67
Resistance Level $27.89 $2.29
Average True Range (ATR) 0.66 0.08
MACD -0.09 -0.03
Stochastic Oscillator 43.77 6.67

Price Performance

Historical Comparison
HNVR
IPHA

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

Share on Social Networks: